Cardiac MRI is a safe and valuable tool to help evaluate patients with acute chest pain

NewsGuard 100/100 Score

An estimated 3 million patients visit emergency departments each year with acute chest pain and mildly elevated troponin levels. High levels of troponin, a protein, occur when the heart muscle is damaged from a heart attack. How best to evaluate and treat patients with chest pain with detectable or mildly elevated troponin remains unclear.

Now, a new study from researchers at Wake Forest University School of Medicine reveals that cardiac magnetic resonance imaging (MRI), is a safe and valuable tool to help evaluate these complex patients.

The study findings appear online today in Circulation: Cardiovascular Imaging, a journal of the American Heart Association.

Patients who present to the emergency room with chest pain and mildly elevated troponin often fall into a diagnostic gray zone. It's not readily clear whether they should have angiography or other forms of testing when being evaluated in the emergency department."

Chad Miller, M.D., professor and chair of emergency medicine at Wake Forest University School of Medicine and emergency medicine physician at Atrium Health Wake Forest Baptist

Angiography is used to check the health of blood vessels and how blood flows through them, but angiography procedures are more invasive than MRI. For example, during cardiac catheterization, a catheter is guided through a patient's blood vessel to the heart. Providers use the test to identify conditions such as clogged arteries.

For the study, researchers randomized 312 participants at four sites in the U.S. to either cardiac MRI or more invasive-based interventions with modification as needed when conditions evolved. The sites included William Beaumont Hospital in Royal Oak, Mich., the University of Mississippi in Jackson; The Ohio State University Wexner Medical Center in Columbus; and Atrium Health Wake Forest Baptist Medical Center in Winston-Salem.

Participants were followed for 2.8 years. The average age of study participants was 61; 60% were men, 64% were white, and 34% were Black. All participants experienced acute chest pain and troponin levels between detectable and 1.0 ng/ml.

The research team compiled data on heart attacks, deaths, and cardiac-related hospital readmission or emergency visits.

"We did not detect any differences in clinical or safety event rates between cardiac MRI and the invasive-based care pathway," Miller said. "We also found that using cardiac MRI reduced the need for invasive angiography over the long-term follow-up period."

In the cardiac MRI group, 58% of participants were safely discharged based on negative imaging and did not have angiography or an intervention such as revascularization within 90 days. Revascularization involves treatment to restore blood flow to a section of the heart that is blocked.

"These findings confirm that cardiac MRI is a highly accurate test that can be reliably used as first-line testing in this complex patient population," Miller said.

Source:
Journal reference:

Miller, C. D., et al. (2023) Cardiac MRI versus Invasive-based Strategies in Patients with Chest Pain and Detectable to Mildly Elevated Serum Troponin: A Randomized Clinical Trial. Circulation Cardiovascular Imaging. doi.org/10.1161/CIRCIMAGING.122.015063.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Non-viral gene therapy offers hope for chronic low back pain sufferers